Dasatinib and Doxorubicin Treatment of Sarcoma Initiating Cells: A Possible New Treatment Strategy

Figure 1

The growth and the sensitivity to doxorubicin of a transformed human mesenchymal (stromal) stem cell line hMSC-TERT4 (solid line) and a derived clonal cell line with the ability to form sarcoma-like tumours in mice hMSC-TERT20-CE8 (CE8, dashed line). The doxorubicin experiments were performed twice with 9 replicates (for the two highest doxorubicin concentrations the experiment was performed once and with 6 replicates). The mean fold change in growth is shown with 95% confidence interval.

(a)

(b)